Ivan Nemazanyy

2.7k total citations
81 papers, 1.7k citations indexed

About

Ivan Nemazanyy is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Ivan Nemazanyy has authored 81 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Ivan Nemazanyy's work include PI3K/AKT/mTOR signaling in cancer (13 papers), Neurological diseases and metabolism (9 papers) and RNA modifications and cancer (9 papers). Ivan Nemazanyy is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (13 papers), Neurological diseases and metabolism (9 papers) and RNA modifications and cancer (9 papers). Ivan Nemazanyy collaborates with scholars based in France, Ukraine and United Kingdom. Ivan Nemazanyy's co-authors include Ganna Panasyuk, Valeriy Filonenko, Mario Pende, Ivan Gout, Alexander Zhyvoloup, Bert Blaauw, Tim R. Fenton, Shannon M. White, Chunling Yi and Mong‐Lien Wang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ivan Nemazanyy

77 papers receiving 1.7k citations

Peers

Countries citing papers authored by Ivan Nemazanyy

Since Specialization

Citations

This map shows the geographic impact of Ivan Nemazanyy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Nemazanyy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Nemazanyy more than expected).

Fields of papers citing papers by Ivan Nemazanyy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Nemazanyy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Nemazanyy. The network helps show where Ivan Nemazanyy may publish in the future.

Co-authorship network of co-authors of Ivan Nemazanyy

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Nemazanyy. A scholar is included among the top collaborators of Ivan Nemazanyy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Nemazanyy. Ivan Nemazanyy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell Plasticity in a Mouse Model of Benign Prostate Hyperplasia Drives Amplification of Androgen-Independent Epithelial Cell Populations Sensitive to Antioxidant Therapy 2023 ·American Journal Of Pathology ·(unknown), (unknown), (unknown), (unknown), Marine Luka, Natascha Pigat, (unknown), E. Navarro, J. Anract, Nicolas Barry Delongchamps, Nicolas Cagnard, Frédéric Bost, Ivan Nemazanyy, Olivier Petitjean, Ahmed Hamaï, Mickaël Ménager, Stéfano Palea, Jacques‐Emmanuel Guidotti, Vincent Goffin	3
2	mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions 2023 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), Rima Elhage, Christophe Desterke, (unknown), Ida Chiara Guerrera, (unknown), Sylvie Souquère, Gérard Pierron, Ivan Nemazanyy, Mairead Kelly, Élise Dalmas, Yunhua Chang, Vincent Goffin, Maryam Mehrpour, Ahmed Hamaï	13
3	Class 3 PI3K coactivates the circadian clock to promote rhythmic de novo purine synthesis 2023 ·Nature Cell Biology ·(unknown), (unknown), Volodymyr Petrenko, Yui Shibayama, (unknown), (unknown), Ivan Nemazanyy, (unknown), Amare Desalegn Wolide, (unknown), Xin Tong, Teruya Tamaru, Takeaki Ozawa, M Girard, Karim Hnia, Dominik Lutter, Charna Dibner, Ganna Panasyuk	6
4	Intratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer 2023 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), Ivan Nemazanyy, Oliver Kepp, Guido Kroemer, Sophie Mouillet‐Richard, Pierre Laurent‐Puig, Valérie Taly, Wenjin Xiao	12
5	Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis 2023 ·Nature Communications ·(unknown), Juan Diego Hernández‐Camacho, (unknown), (unknown), Thomas Cokelaer, Thibault Chaze, Quentin Giai Gianetto, Mariette Matondo, Anastasia D. Gazi, Ivan Nemazanyy, David A. Stroud, Daniella H. Hock, Erminia Donnarumma, Timothy Wai	16
6	Class 3 phosphoinositide 3‐kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity 2022 ·Acta Physiologica ·Yui Shibayama, (unknown), Ivan Nemazanyy, (unknown), Nicolas Cagnard, M Girard, Tatsuya Atsumi, Ganna Panasyuk	2
7	Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression 2022 ·Science Advances ·(unknown), (unknown), Ivan Nemazanyy, (unknown), (unknown), (unknown), (unknown), Nicolas Nottet, Waikin Chan, Philip L. Lorenzi, Sandrine Marchetti, Jean‐Ehrland Ricci, Johanna Chiche	19
8	The Amyotrophic Lateral Sclerosis M114T PFN1 Mutation Deregulates Alternative Autophagy Pathways and Mitochondrial Homeostasis 2022 ·International Journal of Molecular Sciences ·Elisa Teyssou, (unknown), Delphine Roussel, Nirma D. Perera, Ivan Nemazanyy, Dominique Langui, Mélanie Albert, (unknown), (unknown), François Salachas, Pierre‐François Pradat, Vincent Meininger, Philippe Ravassard, Francine Côté, Christian S. Lobsiger, Séverine Boillée, Bradley J. Turner, Danielle Seilhean, Stéphanie Millecamps	12
9	Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting 2022 ·Science ·Patrick Jouandin, Zvonimir Marelja, (unknown), Andrey A. Parkhitko, (unknown), John M. Asara, Ivan Nemazanyy, Christian C. Dibble, Matias Simons, Norbert Perrimon	50
10	Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury 2022 ·JCI Insight ·Anna Maria Rinaldi, Hélène Lazareth, Virginie Poindessous, Ivan Nemazanyy, Júlio L. Sampaio, (unknown), Yohan Bignon, Maarten Naesens, Marion Rabant, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet	35
11	The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer 2021 ·Oncogene ·Seng Chuan Tang, (unknown), Olivier Peulen, (unknown), (unknown), Alice Mayer, (unknown), Pierre Close, Sebastian Klein, Alexandra Florin, Reinhard Büttner, Ivan Nemazanyy, Kateryna Shostak, Alain Chariot	10
12	The pentose phosphate pathway constitutes a major metabolic hub in pathogenic Francisella 2021 ·PLoS Pathogens ·(unknown), Anne Jamet, Jason Ziveri, Elodie Ramond, Mathieu Coureuil, (unknown), Daniel Euphrasie, Fabiola Tros, Nicolas Goudin, Cérina Chhuon, Ivan Nemazanyy, (unknown), Carlos Alberto Labate, Ida Chiara Guerrera, Alain Charbit	25
13	Cell stress response impairs de novo NAD+ biosynthesis in the kidney 2021 ·JCI Insight ·Yohan Bignon, Anna Maria Rinaldi, (unknown), Virginie Poindessous, Ivan Nemazanyy, Olivia Lenoir, (unknown), (unknown), Alexandre Hertig, Alexandre Karras, Pierre Galichon, Maarten Naesens, Dany Anglicheau, Pietro E. Cippà, Nicolas Pallet	33
14	ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis 2021 ·International Journal of Molecular Sciences ·(unknown), Mégane Brusson, Sylvie Cochet, Tatiana Galochkina, Bruno Cassinat, Ivan Nemazanyy, Thierry Peyrard, Jean‐Jacques Kiladjian, Alexandre G. de Brevern, Slim Azouzi, Wassim El Nemer	2
15	Chronic Staphylococcus aureus Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence 2019 ·Clinical Infectious Diseases ·Xin Tan, Mathieu Coureuil, Elodie Ramond, Daniel Euphrasie, Marion Dupuis, Fabiola Tros, Julie Meyer, Ivan Nemazanyy, Cérina Chhuon, Ida Chiara Guerrera, Agnès Ferroni, Isabelle Sermet‐Gaudelus, Xavier Nassif, Alain Charbit, Anne Jamet	34
16	Transketolase of Staphylococcus aureus in the Control of Master Regulators of Stress Response During Infection 2019 ·The Journal of Infectious Diseases ·Xin Tan, Elodie Ramond, Anne Jamet, (unknown), (unknown), Marion Dupuis, Daniel Euphrasie, Fabiola Tros, Ivan Nemazanyy, Jason Ziveri, Xavier Nassif, Alain Charbit, Mathieu Coureuil	15
17	The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARα 2019 ·Nature Communications ·(unknown), Ivan Nemazanyy, (unknown), M Girard, Esther Barth, Nicolas Cagnard, Alexandra Montagner, Dominique Chrétien, Elena I. Rugarli, Hervé Guillou, Mario Pende, Ganna Panasyuk	82
18	The Endosomal Protein CEMIP Links WNT Signaling to MEK1–ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids 2018 ·Cancer Research ·(unknown), Ivan Nemazanyy, Florian Rambow, Seng Chuan Tang, Sylvain Delaunay, Lars Tharun, Alexandra Florin, Reinhard Büttner, (unknown), Pierre Close, Jean‐Christophe Marine, Kateryna Shostak, Alain Chariot	37
19	Generation and Characterization of Monoclonal Antibodies to TDRD7 Protein 2008 ·Hybridoma ·(unknown), Ivan Nemazanyy, (unknown), Valeriy Filonenko, Ganna Panasyuk	5
20	Generation and Characterization of Monoclonal Antibodies to Protein Kinase 2 (CK2) β Subunit 2005 ·Hybridoma ·Ganna Panasyuk, Ivan Nemazanyy, (unknown), Valeriy V. Lyzogubov, Ivan Gout, Valeriy Filonenko	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact